Nalbuphine and Tramadol in the treatment of post spinal anesthesia shivering: a randomized control study
DOI:
https://doi.org/10.69656/pjp.v16i4.1263Keywords:
Shivering, Nalbuphine, Tramadol, Anesthesia, Spinal Anesthesia, EffectivenessAbstract
Post-spinal anesthesia shivering is a frequent problem which can lead to certain hazardous complications as lactic acidosis and hypoxemia For the treatment of post-spinal shivering, tramadol and nalbuphine are commonly used and are readily obtainable. Objective: The aim of this study was to determine and compare the effectiveness of these two drugs in the treatment of post-spinal anesthesia shivering. Methodology: This study was conducted in Ayub Teaching Hospital, Abbottabad. It was a randomized controlled trial of 8 months from 26.07.2018-25.03.2019 It was conducted on 156 patients who developed post-shivering after cesarean section. These patients were divided into two groups after randomization with 78 patients in each group. Group 1 patients were given tramadol while Group 2 patients were given nalbuphine both in a dose of 0.5 mg/kg. First base line shivering score of both groups of patients was noted down and then reassessed after 15 minutes of drug administration. Data was analyzed in SPSS 16 using Chi-square test. P-value ?0.05 was considered as significant. Results: Tramadol was found to be effective in 58(74.4%) patients belonging to group 1 and not in 20(25.6%) while nalbuphine was found to be effective in 63(80.8%) patients belonging to group 2 and not in 15(19.2%).The difference between the two groups was found to be statistically insignificant. Conclusion: Both drugs tramadol and nalbuphine were found to be equally effective in the treatment of shivering after spinal anaesthesia.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Pakistan Journal of Physiology, Pak J Physiol, PJP is FREE for research and academic purposes. It can be freely downloaded and stored, printed, presented, projected, cited and quoted with full reference of, and acknowledgement to the author(s) and the PJP. The contents are published with an international CC-BY-ND-4.0 License.